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INTRODUCTION
Hepatosplenic γδ T-cell lymphoma is a rare and aggres-
sive T-cell malignancy characterized by the neoplastic
proliferation of γδ T cells in the hepatic sinusoids and
splenic red pulp (1, 2). An increased number of γδ T cells
has also been reported in the hepatic sinusoids of patients
with chronic viral hepatitis (3). Human γδ T cells exhibit
preferential homing to the sinusoidal areas of lymphoid
tissues and can mediate cellular immune functions in
response to antigenic stimulation (4). However, the exact
mechanism of the proliferation of these cells remains
unknown.
Hepatitis B virus (HBV) infection has been implicated
in the development of hepatocellular carcinoma (5).
Moreover, HBV has been reported to play a pathogenic
role in some cases of hematopoietic and lymphoid
malignancies (6, 7). Although the role of HBV in the
development of malignancies has not been clarified,
integration of HBV-DNA into the cellular DNA of
neoplasm is frequently found and this has been postulated
as essential to HBV-related oncogenesis because of
transcriptional activation function (8).
We report a case of hepatosplenic γδ T-cell lymphoma
associated with chronic B hepatitis. Although HBV-DNA
was absent in lymphoma cells of this patient, proliferation
of γδ T cells by an immune response to HBV infection
might have played a role in the development of hepatosplenic
γδ T-cell lymphoma.
CASE REPORT
A 45-year-old woman had suffered from liver dys-
function since 1990. Although the opportunity of HBV
infection was not known, a diagnosis of chronic hepatitis B
was made on the basis of the clinical course and antibody
responses against HBV. She was subsequently lost to
follow-up for almost 6 years and there was no data on
serological examination. In 1996 she presented with
jaundice and abdominal fullness. Physical examination
revealed ascites and marked hepatosplenomegaly associ-
ated with no lymphadenopathy. The hemoglobin level was
10.8 g/dl, platelet count 39 x 109/l and white blood cell
count 9.3x109/l with 57% abnormal lymphoid cells
showing irregular nuclei with condensed chromatin. The
lymphoid cells from the peripheral blood expressed CD3,
CD7 and the γδ T-cell receptor detected by TCRδ 1 (T Cell
Sciences, Cambridge, MA), but not the αβ T-cell receptor
detected by TCR 1 (Becton Dickinson, San Jose, CA).
Other T-cell antigens (CD1, CD2, CD4, CD5, CD8, CD25),
NK-cell antigens (CD 16, CD５6, CD57), B-cell antigens
(CD19, CD20) or HLA-DR were negative. The cytogenetic
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analysis of the tumor cells showed an abnormal karyotype ;
47, XX, -13, +2 mar in all 20 metaphases examined. A
clonal rearrangement of the T-cell receptor (TCR)-β, -γ, -δ
chain genes was demonstrated but the immunoglobulin
heavy chain (IgH) gene was in a germ line state by Southern
blot analysis (Fig 1). Serum aspartate aminotransferase
was 856 IU/l, alanine aminotransferase 1056 IU/l, alkaline
phosphatase 447 IU/l, lactate dehydrogenase 1254 IU/l,
total bilirubin 10.1 x 10-2g/l, albumin 32 g/l, ammonia
1.35x10-3g/l and soluble interleukin (IL)-2 receptor 4060U/ml
(normal range 187.6-637.7). Alpha-fetoprotein and carcino-
embryonic antigen were not elevated. Serological tests for
human T-cell lymphotropic virus type I and hepatitis C
virus (HCV) were negative. Hepatitis B surface antigen
was negative. HBV infection was documented by the
presence of IgG anti-HBc and anti-HBs antibodies in
serum. To explore the possibility that lymphoma cells
may become infected with HBV, integration of HBV-DNA
was examined by polymerase chain reaction analysis as
described previously (9). However, HBV-DNA was not
detected in tumor cells. Computed tomography showed
an enlarged liver and spleen and peritoneal fluid. No
malignant cells were found in ascites. Histological features
of the bone marrow showed an infiltration of lymphoma
cells. A liver biopsy specimen showed fibrosis of the portal
areas and sinusoidal infiltration of tumor cells (Fig 2).
These cells were medium-sized lymphocytes with a
regular or slightly indented nucleus, and positive for CD3
and CD45RO (UCHL-1) while negative for CD20 (L-26) by
immunohistochemistry (data not shown). These findings
were compatible with those of hepatosplenic γδ T-cell
lymphoma and chronic hepatitis. Chemotherapy was
started, but shortly after she developed fungal meningitis
and died. Examination at autopsy revealed lymphoid
infiltration in the liver, spleen, kidney, lung, bone marrow,
anterior mediastinum and esophagus. The spleen weighed
500 g and the red pulp was massively infiltrated by
medium-sized neoplastic cells.
DISCUSSION
We report a case of hepatosplenic γδ T-cell lymphoma
in leukemic phase associated with HBV infection.
Aggravation of liver functions in this case was considered
as a rapid progression of chronic hepatitis B until the
proliferation of γδ T cells was found in the peripheral
blood and liver. Clonal expansion of neoplastic cells was
also demonstrated by cytogenetic and genotypic studies.
However, the pathological significance of this chromo-
some abnormality is unknown and its possible role in the
pathogenesis of γ δ T-cell lymphoma remains to be
elucidated. To our best knowledge, there was no case
report of hepatosplenic γδ T-cell lymphoma associated
with chronic hepatitis or HBV infection.
Because HBV is both a hepatotropic and lymphotropic
virus, the possible pathogenic relationship between
hepatitis B and malignant lymphoma has been suggested.
Talamo et al. have reported an autopsy case of primary
hepatic lymphoma in a patient with hepatocellular
carcinoma associated with HBV infection and speculated
that HBV could have been the common cause of both
neoplasms in the liver (10). In addition, Pontisso et al have
reported the detection of HBV-DNA in bone marrow cells
of leukemia patients (6). In contrast, HBV gene products
have been identified in endothelial cells of the tumor
tissues of leukemia and lymphoma patients, suggesting
that HBV-infected endothelial cells support and stimulate
the tumor growth by producing cytokines (7). However,
we were unable to demonstrate HBV-DNA in tumor cells by
polymerase chain reaction analysis and there is no evidence
to suggest a direct role of HBV in the development of
Fig.1. Southern blot analysis of DNA from peripheral blood
lymphocytes of the patient (P) and control placenta (C) using
TCR-β (cβ2), TCR-γ (Jγ1), TCR-δ (Jδ1) and IgH (JH) as probes.
Arrowheads indicate the rearranged bands. Molecular sizes (in
kilobases) are given in Lane MW.
a
b
Fig.2. (a) Histological features of the liver showing fibrosis of the
portal areas (hematoxylin and eosin stain, x 33). (b) Tumor cells
infiltrate the hepatic sinuses (hematoxylin and eosin stain, x 200).
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hepatosplenic γδ T-cell lymphoma in the present patient.
Nevertheless, histological findings showed fibrosis of
the portal areas, indicating a chronic inflammatory change
of the liver in this case. Primary lymphomas may arise as
a monoclonal outgrowth from a pool of proliferating
polyclonal lymphocytes involved in a chronic inflammatory
process. An increased number of γδ T cells together with
CD3+ lymphocyte infiltration has been reported in the
hepatic sinusoids of chronic viral hepatitis(3). Thus, HBV
infection in the liver may provide a chronic stimulation
inciting a γδ T-cell growth. Alternatively, Bukowski et
al have reported the expansion of γδ T cells with the
cytotoxic activity in response to virus-infected cells (11).
This finding suggests that γδ T-cell malignancy may result
from monoclonal expansion of γδ T cells with defined
antigen specificity directed against virus-infected targets.
Taken together, despite the absence of HBV-DNA in
neoplastic γδ T cells, there is a possibility that the γδ T-cell
expansion in response to HBV caused an evolution of
neoplastic γδ T cells. Further investigations are required
to elucidate the relationship between HBV infection and
γδ T-cell malignancy.
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